Alphatec 

€5.1
21
+€0+0% Idag

Statistik

Dagens högsta
5.1
Dagens lägsta
5.1
52V högsta
-
52V lägsta
-
Volym
0
Genomsnittlig volym
-
Marknadsvärde
708.78M
P/E förhållande
-
Utdelningsavkastning
-
Utdelning
-

Kommande

Inkomster

31OctFörväntad
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Nästa
-0.17
-0.13
-0.1
-0.07
Förväntad EPS
-0.096005375
Verklig EPS
Ej tillämpligt

Människor följer också

Den här listan baseras på bevakningslistorna för människor på Stock Events som följer L1Z1.F. Det är inte en investeringsrekommendation.

Konkurrenter

Denna lista är en analys baserad på nyliga marknadshändelser. Det är inte en investeringsrekommendation.

Om

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Show more...
VD
Mr. Patrick S. Miles
Anställda
839
Land
US
ISIN
US02081G2012
WKN
000A2AP5V

Noteringar